Your session is about to expire
← Back to Search
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Mild to Moderate OCD severity (8 ≤ Y-BOCS ≤ 23)
Subjects currently on medication that wish to participate in the study: Taking a confirmed adequate and stable dose of a Serotonin Reuptake Inhibitor (SRI) or Selective Serotonin Reuptake Inhibitor (SSRI), as determined by the Investigator, for at least 6 consecutive weeks prior to screening
Must not have
Be younger than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Upendpoint (week 6), follow-up (week 10)
Awards & highlights
No Placebo-Only Group
Study Summary
This trial is testing a new app to help people with OCD who are also receiving outpatient therapy. The app provides treatment via computerized exposure and response prevention, and the trial will evaluate its safety and effectiveness.
Eligible Conditions
- Obsessive-Compulsive Disorder
Eligibility Criteria
Inclusion Criteria
You will be eligible if you check “Yes” for the criteria belowSelect...
You have a certain level of severity in your symptoms, as determined by a rating scale called the CGI-Severity score.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ endpoint (week 6), follow-up (week 10)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~endpoint (week 6), follow-up (week 10)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Yale-Brown Obsessive-Compulsive Scale (Y-BOCs)
Secondary outcome measures
Beck Anxiety Inventory
Mental Depression
Clinical Global Impression - Improvement scale (CGI-I)
+1 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: BIXINK OC FreeExperimental Treatment1 Intervention
A 6 week ERP-based intervention
Find a Location
Who is running the clinical trial?
BIXINK Therapeutics Co., Ltd.Lead Sponsor
Eric Hollander, MDPrincipal InvestigatorSpectrum Neuroscience and Treatment Institute
16 Previous Clinical Trials
619 Total Patients Enrolled
2 Trials studying Obsessive-Compulsive Disorder
187 Patients Enrolled for Obsessive-Compulsive Disorder
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Who else is applying?
What state do they live in?
New Jersey
New York
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
Spectrum Neuroscience and Treatment Institute
How many prior treatments have patients received?
1
Why did patients apply to this trial?
Have been struggling with trichotillomania for 5 years. This is the most obvious manifestation of my OCD as well as obsessive thoughts and rumination.
PatientReceived 1 prior treatment
How responsive is this trial?
Typically responds via
Phone Call
Most responsive sites:
- Spectrum Neuroscience and Treatment Institute: < 24 hours
Average response time
- < 1 Day
Recent research and studies
Share this study with friends
Copy Link
Messenger